Mark S. Paller

5.1k total citations · 1 hit paper
70 papers, 4.2k citations indexed

About

Mark S. Paller is a scholar working on Nephrology, Molecular Biology and Pediatrics, Perinatology and Child Health. According to data from OpenAlex, Mark S. Paller has authored 70 papers receiving a total of 4.2k indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Nephrology, 18 papers in Molecular Biology and 8 papers in Pediatrics, Perinatology and Child Health. Recurrent topics in Mark S. Paller's work include Acute Kidney Injury Research (16 papers), Heme Oxygenase-1 and Carbon Monoxide (9 papers) and Electrolyte and hormonal disorders (5 papers). Mark S. Paller is often cited by papers focused on Acute Kidney Injury Research (16 papers), Heme Oxygenase-1 and Carbon Monoxide (9 papers) and Electrolyte and hormonal disorders (5 papers). Mark S. Paller collaborates with scholars based in United States, Australia and Israel. Mark S. Paller's co-authors include TF Ferris, J. R. Hoidal, Brian M. Murray, Thomas F. Ferris, Joseph J. Sikora, Eddie L. Greene, Bo E. Hedlund, Harry S. Jacob, Robert P. Hebbel and Mark E. Rosenberg and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Clinical Investigation and Blood.

In The Last Decade

Mark S. Paller

70 papers receiving 4.0k citations

Hit Papers

Oxygen free radicals in ischemic acute renal failure in t... 1984 2026 1998 2012 1984 250 500 750

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mark S. Paller United States 33 1.2k 1.0k 743 648 550 70 4.2k
Richard A. Zager United States 37 1.6k 1.3× 1.7k 1.7× 1.1k 1.5× 403 0.6× 512 0.9× 75 5.0k
Wilfred Lieberthal United States 41 1.7k 1.4× 2.4k 2.3× 909 1.2× 723 1.1× 871 1.6× 79 5.9k
Minoru Ohno Japan 36 1.1k 1.0× 1.2k 1.2× 579 0.8× 765 1.2× 680 1.2× 88 3.8k
Raymond Ardaillou France 42 1.2k 1.0× 1.9k 1.8× 510 0.7× 973 1.5× 247 0.4× 260 6.0k
Diego Rodrı́guez-Puyol Spain 37 1.3k 1.1× 1.5k 1.5× 481 0.6× 1.0k 1.6× 466 0.8× 172 4.6k
Yukio Maruyama Japan 37 682 0.6× 1.9k 1.9× 972 1.3× 531 0.8× 758 1.4× 293 5.8k
Keishi Abe Japan 33 846 0.7× 854 0.8× 755 1.0× 510 0.8× 213 0.4× 286 4.9k
Adrian Iaina Israel 37 1.6k 1.3× 527 0.5× 647 0.9× 1.0k 1.6× 282 0.5× 162 6.0k
Muhammad M. Yaqoob United Kingdom 36 1.6k 1.4× 1.2k 1.2× 561 0.8× 774 1.2× 476 0.9× 132 4.6k
Valentina Kon United States 43 1.5k 1.2× 1.3k 1.3× 850 1.1× 1.4k 2.2× 224 0.4× 135 5.6k

Countries citing papers authored by Mark S. Paller

Since Specialization
Citations

This map shows the geographic impact of Mark S. Paller's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark S. Paller with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark S. Paller more than expected).

Fields of papers citing papers by Mark S. Paller

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark S. Paller. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark S. Paller. The network helps show where Mark S. Paller may publish in the future.

Co-authorship network of co-authors of Mark S. Paller

This figure shows the co-authorship network connecting the top 25 collaborators of Mark S. Paller. A scholar is included among the top collaborators of Mark S. Paller based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mark S. Paller. Mark S. Paller is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Paller, Mark S., Cindy M. Martin, & Mary Ella Pierpont. (2018). Restrictive Cardiomyopathy: An Unusual Phenotype of a Lamin A Variant. ESC Heart Failure. 5(4). 724–726. 12 indexed citations
2.
Paller, Mark S. & Frank B. Cerra. (2006). Investing in Research: The Impact of One Academic Health Center???s Research Grant Program. Academic Medicine. 81(6). 520–526. 20 indexed citations
3.
Paller, Mark S., et al.. (1998). Nitric oxide—mediated renal epithelial cell injury during hypoxia and reoxygenation. Renal Failure. 20(3). 459–469. 39 indexed citations
4.
DuBose, Thomas D., David G. Warnock, Ravindra L. Mehta, et al.. (1997). Acute renal failure in the 21st century: Recommendations for management and outcomes assessment. American Journal of Kidney Diseases. 29(5). 793–799. 72 indexed citations
5.
DuBose, Thomas D., David G. Warnock, Ravindra L. Mehta, et al.. (1997). Acute renal failure in the 21st century. American Journal of Kidney Diseases. 29(5). 4 indexed citations
6.
Tolkoff-Rubin, Nina, Mark S. Paller, Bradley J. Maroni, et al.. (1994). What are the Important Considerations in the Care of Critically III Patients with Acute Renal Failure?. Seminars in Dialysis. 7(2). 103–116. 1 indexed citations
7.
Paller, Mark S.. (1994). Lateral mobility of Na,K-ATPase and membrane lipids in renal cells. Importance of cytoskeletal integrity. The Journal of Membrane Biology. 142(1). 127–35. 31 indexed citations
8.
Pollak, Raymond, et al.. (1993). A RANDOMIZED DOUBLE-BLIND TRIAL OF THE USE OF HUMAN RECOMBINANT SUPEROXIDE DISMUTASE IN RENAL TRANSPLANTATION. Transplantation. 55(1). 57–60. 50 indexed citations
9.
Paller, Mark S., et al.. (1992). Prostaglandins protect kidneys against ischemic and toxic injury by a cellular effect. Kidney International. 42(6). 1345–1354. 70 indexed citations
10.
Manske, Connie L., et al.. (1992). Henoch-Schönlein Vasculitis as a Manifestation of IgA-Associated Disease in Cirrhosis. American Journal of Kidney Diseases. 20(4). 400–402. 16 indexed citations
11.
Paller, Mark S.. (1992). Free Radical-Mediated Postischemic Injury in Renal Transplantation. Renal Failure. 14(3). 257–260. 39 indexed citations
12.
Paller, Mark S.. (1991). Hydrogen peroxide and ischemic renal injury: Effect of catalase inhibition. Free Radical Biology and Medicine. 10(1). 29–34. 25 indexed citations
13.
Paller, Mark S., et al.. (1991). Reactive oxygen species and rat renal epithelial cells during hypoxia and reoxygenation. Kidney International. 40(6). 1041–1049. 136 indexed citations
14.
Rosenberg, Mark E. & Mark S. Paller. (1991). Differential gene expression in the recovery from ischemic renal injury. Kidney International. 39(6). 1156–1161. 83 indexed citations
15.
Nath, Karl A., et al.. (1990). Dietary deficiency of antioxidants exacerbates ischemic injury in the rat kidney. Kidney International. 38(6). 1109–1117. 61 indexed citations
16.
Paller, Mark S.. (1990). Drug-Induced Nephropathies. Medical Clinics of North America. 74(4). 909–917. 50 indexed citations
17.
Paller, Mark S., Barbara S. Daniels, & Thomas H. Hostetter. (1989). Severe Flank Pain as the Predominant Symptom of IgA Nephropathy. American Journal of Kidney Diseases. 13(6). 494–496. 2 indexed citations
18.
Paller, Mark S.. (1989). Potassium Depletion and Regulation of Angiotensin II Receptors in Vascular Smooth Muscle Cells. Journal of Receptor Research. 9(1). 95–106. 1 indexed citations
19.
Paller, Mark S., et al.. (1988). Cyclosporine augments the renal vasoconstrictor response to norepinephrine ne. Kidney International. 33(1). 442. 3 indexed citations
20.
Paller, Mark S. & Brian M. Murray. (1985). Renal dysfunction in animal models of cyclosporine toxicity.. PubMed. 17(4 Suppl 1). 155–9. 43 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026